Inclusion of Older Adults in Cancer Clinical Trials

On 2 March 2022 the FDA published the final guidance for industry.

This guidance provides recommendations regarding the inclusion of older adult patients in clinical trials of drugs for the treatment of cancer. For the purpose of this final guidance, older adults are those age 65 years and older. The final guidance emphasizes the particular importance of including adults over age 75 years in cancer clinical trials. Specifically, this final guidance includes recommendations for including an adequate representation of older adults in cancer clinical trials to better enable evaluation of the benefit-risk profile of cancer drugs in this population.

Read more online 
Copyright Widler & Schiemann AG 2020. All Rights Reserved. /